GTS Securities’s CRISPR Therapeutics CRSP Stock Holding History

GTS Securities’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.34M	Buy
2024 Q4	–	Sell
2024 Q3	$2.42M	Buy
2024 Q2	$2.23M	Buy
2024 Q1	$1.31M	Sell
2023 Q4	$4.34M	Buy
2023 Q3	$1.88M	Buy
2023 Q2	$1.55M	Buy